Product NDC: | 0085-1328 |
Proprietary Name: | NOXAFIL |
Non Proprietary Name: | posaconazole |
Active Ingredient(s): | 40 mg/mL & nbsp; posaconazole |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0085-1328 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022003 |
Marketing Category: | NDA |
Start Marketing Date: | 20060915 |
Package NDC: | 0085-1328-01 |
Package Description: | 1 BOTTLE, GLASS in 1 CARTON (0085-1328-01) > 105 mL in 1 BOTTLE, GLASS |
NDC Code | 0085-1328-01 |
Proprietary Name | NOXAFIL |
Package Description | 1 BOTTLE, GLASS in 1 CARTON (0085-1328-01) > 105 mL in 1 BOTTLE, GLASS |
Product NDC | 0085-1328 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | posaconazole |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20060915 |
Marketing Category Name | NDA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | POSACONAZOLE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |